Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess pop...
Autors principals: | , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Taylor & Francis Group
2022-11-01
|
Col·lecció: | Human Vaccines & Immunotherapeutics |
Matèries: | |
Accés en línia: | http://dx.doi.org/10.1080/21645515.2022.2096375 |
_version_ | 1827806402052096000 |
---|---|
author | Dong Li Hairong Zhang Na You Zhifei Chen Xiuhui Yang Hangsu Zhang Yong Zhou Ningxuan Zheng Weiyi Pan |
author_facet | Dong Li Hairong Zhang Na You Zhifei Chen Xiuhui Yang Hangsu Zhang Yong Zhou Ningxuan Zheng Weiyi Pan |
author_sort | Dong Li |
collection | DOAJ |
description | Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess population immunity to mumps and identify risk factors for mumps. Methods We conducted a cross-sectional serosurvey of mumps IgG antibodies in the general population of Fujian Province in 2018 and compare results with a similar study conducted in 2009, when the routine schedule had no MuCV. We analyzed changes in mumps epidemiology after implementation of a one-dose MuCV vaccination strategy. Results Mumps seroprevalence was 78.6% (95% CI: 77.4–79.8), and the geometric mean concentration (GMC) of mumps antibodies was 245.8 IU/ml (95% CI:237.3–255.1). MuCV vaccination at 18 months resulted in increased seroprevalence and GMCs. Seroprevalence and GMCs varied by age, gender, and number of doses received. Except for children under 18 months, seroprevalence and GMCs were lowest among 10-15-year-olds. Each year after introduction of the one-dose MuCV vaccination policy, the highest incidence of mumps was among 4–6-year-olds and 9–15-year-olds, gradually shifting to older age groups. Conclusion A one-dose mumps-containing vaccine schedule does not provide sustained and stable mumps immunity in Fujian. To reduce the risk of mumps, we recommend supplementary vaccination of children without a history of receiving at least one MuCV dose or who are seronegative at 10–15 years of age. |
first_indexed | 2024-03-11T21:40:39Z |
format | Article |
id | doaj.art-60d94b51a2f44d08abd9f7b690694d67 |
institution | Directory Open Access Journal |
issn | 2164-5515 2164-554X |
language | English |
last_indexed | 2024-03-11T21:40:39Z |
publishDate | 2022-11-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Human Vaccines & Immunotherapeutics |
spelling | doaj.art-60d94b51a2f44d08abd9f7b690694d672023-09-26T13:19:08ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118610.1080/21645515.2022.20963752096375Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, ChinaDong Li0Hairong Zhang1Na You2Zhifei Chen3Xiuhui Yang4Hangsu Zhang5Yong Zhou6Ningxuan Zheng7Weiyi Pan8Fujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionFujian Provincial Center for Disease Control and PreventionBackground Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess population immunity to mumps and identify risk factors for mumps. Methods We conducted a cross-sectional serosurvey of mumps IgG antibodies in the general population of Fujian Province in 2018 and compare results with a similar study conducted in 2009, when the routine schedule had no MuCV. We analyzed changes in mumps epidemiology after implementation of a one-dose MuCV vaccination strategy. Results Mumps seroprevalence was 78.6% (95% CI: 77.4–79.8), and the geometric mean concentration (GMC) of mumps antibodies was 245.8 IU/ml (95% CI:237.3–255.1). MuCV vaccination at 18 months resulted in increased seroprevalence and GMCs. Seroprevalence and GMCs varied by age, gender, and number of doses received. Except for children under 18 months, seroprevalence and GMCs were lowest among 10-15-year-olds. Each year after introduction of the one-dose MuCV vaccination policy, the highest incidence of mumps was among 4–6-year-olds and 9–15-year-olds, gradually shifting to older age groups. Conclusion A one-dose mumps-containing vaccine schedule does not provide sustained and stable mumps immunity in Fujian. To reduce the risk of mumps, we recommend supplementary vaccination of children without a history of receiving at least one MuCV dose or who are seronegative at 10–15 years of age.http://dx.doi.org/10.1080/21645515.2022.2096375mumpsseroprevalencevaccinationmeasles-mumps-rubella vaccine (mmr)geometric mean concentration (gmc) |
spellingShingle | Dong Li Hairong Zhang Na You Zhifei Chen Xiuhui Yang Hangsu Zhang Yong Zhou Ningxuan Zheng Weiyi Pan Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China Human Vaccines & Immunotherapeutics mumps seroprevalence vaccination measles-mumps-rubella vaccine (mmr) geometric mean concentration (gmc) |
title | Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China |
title_full | Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China |
title_fullStr | Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China |
title_full_unstemmed | Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China |
title_short | Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China |
title_sort | mumps serological surveillance following 10 years of a one dose mumps containing vaccine policy in fujian province china |
topic | mumps seroprevalence vaccination measles-mumps-rubella vaccine (mmr) geometric mean concentration (gmc) |
url | http://dx.doi.org/10.1080/21645515.2022.2096375 |
work_keys_str_mv | AT dongli mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT hairongzhang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT nayou mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT zhifeichen mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT xiuhuiyang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT hangsuzhang mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT yongzhou mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT ningxuanzheng mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina AT weiyipan mumpsserologicalsurveillancefollowing10yearsofaonedosemumpscontainingvaccinepolicyinfujianprovincechina |